QL
LRMR icon

Quarry LP’s Larimar Therapeutics LRMR Stock Holding History

Quarry LP’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,000
Closed -$78.6K – 1853
2024
Q3 		$78.6K Buy
12,000
+4,000
+50% +$32.1K 0.02% 517
2024
Q2 		$58K Buy
8,000
+7,250
+967% +$55.5K 0.02% 577
2024
Q1 		$5.69K Buy
+750
New +$5.84K ﹤0.01% 1306

Other funds holding LRMR

Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

Quarry LP's LRMR Position: Q4 2024 in Review

Quarry LP sold out of Larimar Therapeutics (LRMR) in Q4 2024, closing a stake of 12,000 shares — an estimated $78.6K sold.

Quarry LP first reported a position in LRMR in Q1 2024 and held it in 3 quarters. The position peaked at $78.6K in Q3 2024. 116 funds tracked by Wall St. Rank hold LRMR as of Q4 2024.

  • Quarry LP reported no remaining Larimar Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Quarry LP sold 12,000 Larimar Therapeutics shares in Q4 2024, an estimated $78.6K.
  • Quarry LP first reported a position in Larimar Therapeutics in Q1 2024 and held it in 3 quarters.
  • Quarry LP's Larimar Therapeutics position peaked at $78.6K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q4 2024.

Based on Quarry LP's 13F filing for Q4 2024, filed 14 Feb 2025.